Dr. Richard Wayne Henifin, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 493 Main St Ste C, Diamond Springs, CA 95619 Phone: 530-626-5810 Fax: 530-626-6560 |
Dr. Mitchell Allen Goodis, D.D.S. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 540 Pleasant Valley Rd, Ste 102, Diamond Springs, CA 95619 Phone: 530-344-0290 Fax: 530-344-0291 |
Brock Davidson, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 509 Main St, Diamond Springs, CA 95619 Phone: 530-621-1051 |
News Archive
When children are sick, clinicians can consult a known standard for how their heart, lungs and kidneys should be growing and working.
Mallinckrodt plc, a leading specialty biopharmaceutical company, announced today that it has closed the sale of its global contrast media and delivery systems (CMDS) business to Guerbet in a transaction valued at approximately $270 million.
Aduro BioTech, a clinical-stage immunotherapy company, is pleased to announce the presentation of the CRS-207 Phase 1 study at the AACR Special Conference on Tumor Immunology in Miami, Florida by the Principal Investigator, Dr. Dung Le of the Johns Hopkins Kimmel Cancer Center. Dr. Le reported that CRS-207 intravenous administration was well tolerated in subjects with advanced, treatment-refractory cancers. Dr. Le also reported evidence of immune activation and that 6 out of 17 end-stage cancer patients lived 15 months or longer.
Isis Pharmaceuticals, Inc. announced today top-line results from a Phase 2 study of ISIS-PTP1B Rx in patients with type 2 diabetes. In the Phase 2 study patients treated with ISIS-PTP1B Rx achieved statistically significant reductions in body weight and hemoglobin A1c (HbA1c).
› Verified 6 days ago